Open Access Repository

CCR6/CCL20 chemokine axis in human immunodeficiency virus immunity and pathogenesis

Lee, AYS and Korner, H ORCID: 0000-0003-4610-2814 2017 , 'CCR6/CCL20 chemokine axis in human immunodeficiency virus immunity and pathogenesis' , Journal of General Virology, vol. 98, no. 3 , pp. 338-344 , doi: 10.1099/jgv.0.000691.

Full text not available from this repository.


Recent studies in human immunodeficiency virus (HIV) have garnered interest for the role of CC chemokine receptor 6 (CCR6) and its known ligands, CC chemokine ligand 20 (CCL20) and human β-defensins, in viral entry, dissemination and antiviral immunity. Several studies have suggested that CCR6 may also act as a weak co-receptor of HIV entry, in addition to the canonical CXC chemokine receptor 4 (CXCR4) and CCR5. However, the pathogenic significance has yet to be demonstrated as the observations for preferential infection of CD4+CCR6+ over CD4+CCR6- T cells appear to be independent of CCR6 expression. This indicates means for preferential infection other than CCR6 co-receptor use. Attention has also turned to the inadvertent role of the CCR6/CCL20 axis in attracting key immune cells, including TH17 cells and dendritic cells, to sites of infection and propagating the virus to other sites of the body. This review article will summarize the latest evidence that the CCR6/CCL20 chemokine axis is playing an important role in HIV pathogenesis and immunity. Further work with in vivo studies is needed to establish the biological and, hence, therapeutic significance of these findings.

Item Type: Article
Authors/Creators:Lee, AYS and Korner, H
Journal or Publication Title: Journal of General Virology
Publisher: Soc General Microbiology
ISSN: 0022-1317
DOI / ID Number: 10.1099/jgv.0.000691
Copyright Information:

Copyright 2017 The Authors

Related URLs:
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page